Document is current
Any future updates will be listed below
-
Authors
Walendy, Victor
Stang, Andreas
Girndt, Matthias
-
Funding
Funding for this research was provided by:
Martin-Luther-Universität Halle-Wittenberg
- License Information
-
More Information
Article History
Received: 30 May 2024
Accepted: 3 January 2025
First Online: 9 January 2025
Declarations
:
: The approval of an ethics committee was not obtained because the authors were using anonymized data supplied by the German Federal Bureau of Statistics (DESTATIS). The anonymization of such data is regulated in § 16 Bundesstatistikgesetz (Federal Statistics Act).
: Not applicable.
: The authors declare no competing interests.
: Not applicable.
: Dr. Girndt reports lecture fees from Amgen, Astellas, Bayer Vital, Daiichi.Sankyo, Hexal, Sanofi, Vifor, outside the submitted work; He is engaged in complimentary work for the Commission for Hygiene and Infection Prevention,German Society of Nephrology and as Member of the Board of the German Society for Applied Hygiene in Dialysis.Dr. Walendy received a lecture fee from Bayer Pharmaceuticals and received financial support for congress costs from Lilly Pharma Germany.Dr. Stang has nothing to disclose.
